Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of JYP0061 in adults with severe alopecia areata
CTR20253959Phase 2Active
- Sponsor
- Guangzhou JOYO Pharma
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JYP0061 in alopecia areata, sponsored by Guangzhou JOYO Pharma. Started Sep 2025; status: active.
02
Drugs
JYP0061
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20253959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253959.